
Publications of Karl Herholz
All genres
Journal Article (72)
1.
Journal Article
33 (5), pp. 867 - 877 (2012)
Cholinergic system function and cognition in mild cognitive impairment. Neurobiology of Aging 2.
Journal Article
96 (2), pp. 231 - 239 (2010)
[11C]-l-Methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology 3.
Journal Article
50 (12), pp. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine 4.
Journal Article
28 (3), pp. 259 - 266 (2009)
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dementia and Geriatric Cognitive Disorders 5.
Journal Article
15 (11), pp. 1155 - 1162 (2008)
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. European Journal of Neurology 6.
Journal Article
49 (1), pp. 44 - 49 (2008)
Cortical flattening applied to high-resolution F-18-FDG PET. Journal of Nuclear Medicine 7.
Journal Article
Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map. 12, pp. 1971 - 1980 (2007)
8.
Journal Article
14 (6), pp. 690 - 693 (2007)
Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness. European Journal of Neurology 9.
Journal Article
51 (2), pp. 164 - 181 (2007)
Role of in vivo imaging of the central nervous system for developing novel drugs. Quarterly Journal of Nuclear Medicine and Molecular Imaging 10.
Journal Article
51 (2), pp. 164 - 181 (2007)
Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging 11.
Journal Article
408 (1), pp. 46 - 50 (2006)
Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neuroscience Letters 12.
Journal Article
27 (7), pp. 588 - 597 (2006)
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping 13.
Journal Article
98 (1), pp. 57 - 65 (2006)
From the left to the right: How the brain compensates progressive loss of language function. Brain and Language 14.
Journal Article
33 (5), pp. 516 - 524 (2006)
Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging 15.
Journal Article
30 (3), pp. 871 - 878 (2006)
Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. NeuroImage 16.
Journal Article
47 (2), pp. 302 - 312 (2006)
Brain receptor imaging. Journal of Nuclear Medicine 17.
Journal Article
21 (5-6), pp. 373 - 379 (2006)
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 18.
Journal Article
65 (11), pp. 1716 - 1722 (2005)
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 19.
Journal Article
46 (12), pp. 1948 - 1958 (2005)
F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine 20.
Journal Article
25 (12), pp. 1685 - 1691 (2005)
Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. Journal of Cerebral Blood Flow and Metabolism